MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

Core Viewpoint - A class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. for alleged violations of federal securities laws, particularly concerning inadequate internal controls and improper revenue recognition [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Maravai made false and misleading statements regarding its financial reporting and failed to maintain adequate internal controls [2]. - Allegations include improper revenue recognition from certain transactions in fiscal 2024 and an overstatement of goodwill [2]. Group 2: Investor Information - Shareholders who purchased Maravai's securities between August 7, 2024, and February 24, 2025, are encouraged to contact the DJS Law Group before May 5, 2025, to participate in the lawsuit [1].